SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015856
Filing Date
2020-08-14
Accepted
2020-08-14 16:22:15
Documents
49
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 305530
2 ex31-1.htm EX-31.1 22316
3 ex32-1.htm EX-32.1 8930
  Complete submission text file 0001493152-20-015856.txt   2010187

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE vbio-20200630.xml EX-101.INS 283872
5 XBRL SCHEMA FILE vbio-20200630.xsd EX-101.SCH 34865
6 XBRL CALCULATION FILE vbio-20200630_cal.xml EX-101.CAL 38714
7 XBRL DEFINITION FILE vbio-20200630_def.xml EX-101.DEF 60427
8 XBRL LABEL FILE vbio-20200630_lab.xml EX-101.LAB 216712
9 XBRL PRESENTATION FILE vbio-20200630_pre.xml EX-101.PRE 145436
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53832 | Film No.: 201105426
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services